Wu Xi Bi­o­log­ics moves ahead with 400 job in­vest­ment

The Argus - - NEWS -

LEAD­ING Chi­nese bio­phar­ma­ceu­ti­cal firm WuXi Bi­o­log­ics, which is pro­nounced Wooshie, has an­nounced its in­ten­tion to seek mi­nor al­ter­ations to the plan­ning per­mis­sion granted to IDA Ire­land for a biotech­nol­ogy cam­pus at the IDA Ire­land Dun­dalk Science and Tech­nol­ogy Park.

The pro­posed WuXi Bi­o­log­ics fa­cil­ity is to be lo­cated on a 23-ha site within the 47-ha IDA Ire­land Dun­dalk Science and Tech­nol­ogy Park just off the M1 mo­tor­way at Junc­tion 17, where plan­ning per­mis­sion for a biotech­nol­ogy cam­pus has been in place since 2008.

WuXi Bi­o­log­ics is to seek mi­nor plan­ning amend­ments to the ex­ist­ing plan­ning per­mis­sion for its 23-ha site. These amend­ments in­volve changes to the lay­out of the WuXi Bi­o­log­ics site and carpark, al­ter­ations to the shape of some of the build­ings and a re­duc­tion in the num­ber of build­ings to be con­structed than orig­i­nally en­vis­aged. Con­sid­er­ing the daily com­mute of fu­ture em­ploy­ees and with a view to cre­at­ing a sus­tain­able and con­ve­nient way for staff to ar­rive to work, WuXi Bi­o­log­ics is adding cy­clist chang­ing, dry­ing and shower fa­cil­i­ties to the orig­i­nal plan.

Over­all, the WuXi Bi­o­log­ics build­ings will be both slightly smaller and lower than the orig­i­nal build­ings ap­proved in the IDA Ire­land per­mis­sion, but they will oc­cupy the ap­prox­i­mately the same 45,000m foot­print on the ground.

WuXi Bi­o­log­ics is in­vest­ing €325 mil­lion in the new state-of-the-art man­u­fac­tur­ing fa­cil­ity which will cre­ate 400 high value jobs in the lo­cal re­gion over the com­ing years. It is hoped that per­mis­sion will be granted in time for site­works to com­mence early in 2019 and for con­struc­tion work to move ahead some months later, for com­ple­tion by mid-2020. Some sur­vey work will be com­pleted on site in Oc­to­ber and Novem­ber, in prepa­ra­tion for site de­vel­op­ment.

Re­cruit­ment for the ma­jor­ity of the pro­jected 400 jobs in the new Dun­dalk fa­cil­ity will be­gin in 2020, to pre­pare the fa­cil­ity for pro­duc­tion the fol­low­ing year. In the pe­riod ahead, a num­ber of key manage­ment and se­nior po­si­tions will be filled. The jobs at the fa­cil­ity will range from man­u­fac­tur­ing to tech­ni­cal and qual­ity as­sur­ance roles as well as as­so­ci­ated ad­min­is­tra­tion po­si­tions. There will also be sig­nif­i­cant con­struc­tion em­ploy­ment op­por­tu­ni­ties dur­ing the two-year de­vel­op­ment pe­riod.

The new fa­cil­ity re­flects best-in-class in­dus­try prac­tice glob­ally and rep­re­sents a sig­nif­i­cant step along the jour­ney towards the ‘Fac­tory of the Fu­ture’ con­cept. The fa­cil­ity will in­cor­po­rate in­no­va­tive tech­nol­ogy op­ti­mised for the flex­i­ble pro­duc­tion of a wide range of bi­o­logic drugs for a va­ri­ety of cus­tomers both in Ire­land and in­ter­na­tion­ally.

WuXi Bi­o­log­ics’ mis­sion is to ac­cel­er­ate and trans­form bi­o­log­ics dis­cov­ery, de­vel­op­ment and man­u­fac­tur­ing to ben­e­fit pa­tients world­wide. Head­quar­tered in Wuxi, Jiangsu, China, with three man­u­fac­tur­ing sites lo­cated in Wuxi, Shang­hai and Suzhou, the com­pany is the main player in China’s bi­o­log­ics services mar­ket. The com­pany also holds lead­ing mar­ket po­si­tions glob­ally and is quoted on the Hong Kong Stock Ex­change. WuXi Bi­o­log­ics works with 200 part­ners world­wide, in­clud­ing 13 of the 20 largest global pharma com­pa­nies. WuXi Bi­o­log­ics’ services are de­signed to ac­cel­er­ate the dis­cov­ery and de­vel­op­ment process for the lat­est gen­er­a­tion of bio­phar­ma­ceu­ti­cal drugs, whilst also re­duc­ing the cost of pro­duc­tion. As a fully-in­te­grated bio­phar­ma­ceu­ti­cals con­tract man­u­fac­tur­ing com­pany, WuXi Bi­o­log­ics pro­vides its part­ners with the ad­vanced ca­pa­bil­i­ties, cut­ting-edge tech­nolo­gies and com­pre­hen­sive so­lu­tions to en­able them to de­velop in­no­va­tive bi­o­log­ics medicine.

An il­lus­trant of the pro­posed WuXi Bi­o­log­i­cal site and below a typ­i­cal il­lus­tra­tion of the work process at a WuXi plant.

The map il­lus­trates an out­line of the 2008 plan­ning ap­proval granted by Louth County Coun­cil for the de­vel­op­ment of the strate­gic IDA Ire­land-owned land­bank at Mul­laghar­lin. The WuXi Bi­o­log­ics site is shaded in green, il­lus­trat­ing the pro­posed site lay­out for the planned WuXi Bi­o­log­ics de­vel­op­ment, sub­ject to lo­cal au­thor­ity plan­ning ap­proval.

Newspapers in English

Newspapers from Ireland

© PressReader. All rights reserved.